Diabetic retinopathy (DR) is a leading cause of visual impairment ... STDR was defined as the presence of preproliferative DR (R2), proliferative DR (R3) and/or maculopathy (M1). Photographs that were ...

The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

Dec. 12, 2024 — Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.